Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Craig Reynolds Insider Profile
4 Followers
Craig Reynolds, Director at Symmetry Medical, holds 6.66K shares in Masimo (Ticker: MASI), holds 4.12K shares in Vapotherm (Ticker: VAPO), holds 0.00 shares in Symmetry Medical (Ticker: SMA).
Profitable Transactions
4 out of 6 Profitable Transactions
Average Return
+13.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Craig Reynolds
Craig Reynolds's Trading History
Symmetry Medical
Dec 09, 2014
―
Uninformative Sell
971.25K
―
Vapotherm
Sep 03, 2020
Director
Uninformative Buy
―
$5.21K
Masimo
May 31, 2023
Director
Uninformative Buy
―
$911.68K
List of latest transactions for each holding click on a transaction to see Craig Reynolds's performance on stock
You May Also Like
Craig Reynolds insider profile FAQ
What is the percentage of profitable transactions made by Craig Reynolds?
The percentage of profitable transactions made by Craig Reynolds is 67%.
What is the average return per transaction made by Craig Reynolds?
The average return per transaction made by Craig Reynolds is 13.20%.
What stocks does Craig Reynolds hold?
Craig Reynolds holds: SMA, VAPO, MASI stocks.
What was Craig Reynolds’s latest transaction?
Craig Reynolds latest transaction was an Uninformative Buy of ―.
What was Craig Reynolds's most profitable transaction?
Craig Reynolds’s most profitable transaction was an Informative Buy of MASI stock on June 3, 2019. The return on the trade was 75.70%.
What is Craig Reynolds's role in Symmetry Medical?
Craig Reynolds's role in Symmetry Medical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.